Sofinnova Investments
$1.9B Assets Reported
76 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $310M | 16.2% |
| BMY | Bristol-Myers Squibb Co | 1,988,721 | $121M | 6.3% |
| JAZZ | Jazz Pharmaceuticals PLC | 598,327 | $113M | 5.9% |
| VERA | Vera Therapeutics Inc | 2,793,987 | $112M | 5.9% |
| AZN | AstraZeneca PLC | 456,031 | $90M | 4.7% |
| COGT | Cogent Biosciences Inc | 2,113,551 | $81M | 4.3% |
| CELC | Celcuity Inc | 666,175 | $76M | 4.0% |
| RARE | Ultragenyx Pharmaceutical Inc | 3,495,888 | $73M | 3.8% |
| RAPP | Rapport Therapeutics Inc | 1,904,408 | $60M | 3.1% |
| INSM | Insmed Inc | 346,075 | $57M | 3.0% |
Track Sofinnova Investments's 13F portfolio: $1.9B in reported holdings, 76 positions. Top holdings, AUM, and quarterly changes on SentiSense.